🇺🇸 FDA
Pipeline program

Isoniazid Aminosalicylate Tablets

2013ZX10003009

Approved small_molecule active

Quick answer

Isoniazid Aminosalicylate Tablets for Reinfection Pulmonary Tuberculosis is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Reinfection Pulmonary Tuberculosis
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials